![3-(2-氯乙基)-9-羟基-2-甲基-4H-吡啶并[1,2-a]嘧啶-4-酮结构式](https://www.chemsrc.com/caspic/251/260273-82-3.png)
3-(2-氯乙基)-9-羟基-2-甲基-4H-吡啶并[1,2-a]嘧啶-4-酮结构式
|
常用名 | 3-(2-氯乙基)-9-羟基-2-甲基-4H-吡啶并[1,2-a]嘧啶-4-酮 | 英文名 | 3-(2-Chloroethyl)-9-hydroxy-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one |
|---|---|---|---|---|
| CAS号 | 260273-82-3 | 分子量 | 238.670 | |
| 密度 | 1.4±0.1 g/cm3 | 沸点 | 413.1±55.0 °C at 760 mmHg | |
| 分子式 | C11H11ClN2O2 | 熔点 | N/A | |
| MSDS | N/A | 闪点 | 203.6±31.5 °C |
| 中文名 | 3-(2-氯乙基)-2-甲基-9-羟基-4H-吡啶并[1,2A]嘧啶-4酮 (帕潘立酮) |
|---|---|
| 英文名 | 3-(2-Chloroethyl)-2-methyl-9-hydroxy-4H-pyrido[1,2-a]pyrimidin-4-one (Paliperidone) |
| 中文别名 | 3-(2-氯乙基)-9-羟基-2-甲基-4H-吡啶并[1,2-a]嘧啶-4-酮 | 帕利哌酮杂质1 |
| 英文别名 | 更多 |
| 密度 | 1.4±0.1 g/cm3 |
|---|---|
| 沸点 | 413.1±55.0 °C at 760 mmHg |
| 分子式 | C11H11ClN2O2 |
| 分子量 | 238.670 |
| 闪点 | 203.6±31.5 °C |
| 精确质量 | 238.050903 |
| PSA | 54.60000 |
| LogP | 1.66 |
| 蒸汽压 | 0.0±2.2 mmHg at 25°C |
| 折射率 | 1.635 |
|
~%
3-(2-氯乙基)-9-羟基-... 260273-82-3 |
| 文献：ACTAVIS GROUP PTC EHF Patent: US2010/4447 A1, 2010 ; Location in patent: Page/Page column 3 ; |
|
~63%
3-(2-氯乙基)-9-羟基-... 260273-82-3 |
| 文献：GLENMARK GENERICS LIMITED Patent: WO2009/130710 A2, 2009 ; Location in patent: Page/Page column 17-18 ; |
|
~%
3-(2-氯乙基)-9-羟基-... 260273-82-3 |
| 文献：WATSON LABORATORIES, INC.; CHAVAN, Amit, Anant; BHANU, Manjunath, Narayan; JOSHI, Ashutosh, Vijay Patent: WO2012/134445 A1, 2012 ; Location in patent: Page/Page column 26; 27 ; |
|
~%
3-(2-氯乙基)-9-羟基-... 260273-82-3 |
| 文献：CADILA HEALTHCARE LIMITED; DWIVEDI, Shriprakash, Dhar; PATEL, Dhimant, Jasubhai; ROY, Rushikesh, Udaykumar; PATEL, Mayur, Ramnikbhai Patent: WO2011/73997 A2, 2011 ; |
|
~%
3-(2-氯乙基)-9-羟基-... 260273-82-3 |
| 文献：CADILA HEALTHCARE LIMITED; DWIVEDI, Shriprakash, Dhar; PATEL, Dhimant, Jasubhai; ROY, Rushikesh, Udaykumar; PATEL, Mayur, Ramnikbhai Patent: WO2011/73997 A2, 2011 ; |
|
~%
3-(2-氯乙基)-9-羟基-... 260273-82-3 |
| 文献：CADILA HEALTHCARE LIMITED; DWIVEDI, Shriprakash, Dhar; PATEL, Dhimant, Jasubhai; ROY, Rushikesh, Udaykumar; PATEL, Mayur, Ramnikbhai Patent: WO2011/73997 A2, 2011 ; Location in patent: Page/Page column 14 ; |
| 4H-Pyrido[1,2-a]pyrimidin-4-one, 3-(2-chloroethyl)-9-hydroxy-2-methyl- |
| 3-(2-chloroethyl)-9-hydroxy-2-methyl-4H-pyrido[1,2-a]pyrimidine-4-one |
| 3-(2-Chloroethyl)-2-methyl-9-hydroxy-4H-pyrido[1,2-a]pyrimidin-4-one(Paliperidone) |
| 3-(2-chloroethyl)-2-methyl-9-hydroxy-4H-pyrido[1,2-a]pyrimidin-4-one |
| 3-(2-chloroethyl)-2-Methyl-9-hydroxy-4H-pyrido[1,2-a]pyriMidine-4-one |
| 9-hydroxy-3-(2-chloroethyl)-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one |
| 3-(2-chloroethyl)-6,7,8,9-tetrahydro-9-hydroxy-2- methyl-4H-pyrido [1,2-a]pyrimidine-4-one |
| MFCD11110969 |
查看所有供应商和价格请点击：
![3-(2-氯乙基)-2-甲基-9-苄氧基-4H-吡啶并[1,2A]嘧啶-4酮 (帕潘立酮)结构式](https://www.chemsrc.com/caspic/269/147687-17-0.png)
![3-(2-氯乙基)-6,7,8,9-四氢-9-羟基-2-甲基-4H-吡啶并[1,2-a]嘧啶-4-酮结构式](https://www.chemsrc.com/caspic/315/130049-82-0.png)
![3-(2-chloroethyl)-9-hydroxy-2-methylpyrido[1,2-a]pyrimidin-4-one,hydrochloride结构式](https://www.chemsrc.com/caspic/213/849727-62-4.png)